Three Brands We Recommend Are Telling You to Stock Up Before December 11

Affiliate disclosure: MyCannabisReviews.com earns a commission when you buy through links on this page, at no extra cost to you. Every brand named here pays us that commission, and our scores are set by the review process rather than the payout. Every storefront quote below is transcribed verbatim from that brand’s own public pages, on the date stated.

The Short Verdict

On 25 September 2026 we read the storefronts of six hemp brands we recommend. Three of them — Vena, Soul and Five — are actively telling shoppers to stock up before new federal rules land in December. On the pages we read, three — Koi, Medterra and CBDfx — printed nothing of the kind.

The new part is this: Soul now prints the calendar date in plain text. Not a vague “last chance” banner — the words “Ships until December 11, 2026” and “The federal THC ban takes effect December 11. We cannot ship after that and there is no reorder.” One of its purchase tiers is labelled “Try before the ban.”

Why that matters: 11 December 2026 is the date our reading of the statute points to, from the subclause structure of Section 2019 of Public Law 119-103. It is a minority reading among the law firms we have read — most of them say 12 November. But three operators have now landed on December, and one of them has put the date in its buy box.

That is not legal authority, and we are not presenting it as any. It is something arguably more useful to a shopper than a legal opinion: it is what the companies that actually have to ship these products believe is about to happen.

What Each Brand Actually Prints

Every quote below was transcribed on the date shown, using a strict transcription pass that offered an explicit “none printed” option for each category — so the blanks are findings, not gaps in our reading. MCR Scores are the brand scores from our comparison hub, unchanged by this story.

Read the table honestly: a blank cell means we found no such language on the pages we read, on the dates shown. It does not mean the brand has no view, and it does not mean nothing will appear next week. Storefront copy changes daily — that is rather the point of this article.

Soul Printed the Date. That Is the Story.

Until this week the operator evidence was suggestive: urgency banners, the word “December”, countdown timers you had to do arithmetic on. On 25 September, Soul’s Out of Office product page printed all of this, verbatim:

“The federal THC ban ends shipping on December 11.”

“The federal THC ban takes effect December 11. We cannot ship after that and there is no reorder.”

“Ships until December 11, 2026”

“Last ship date Dec 11.”

And on Soul’s homepage the same day: “Out of Office stops shipping December 11” and “New nation-wide regulations mean that all OOO THC products can no longer be shipped after this date.”

Two things to be precise about, because nobody else will be. First, this is Soul’s characterisation, not a statute. There is no federal instrument that uses the words “THC ban”. What exists is a redefinition of hemp in Section 781 of Public Law 119-37, and a partial delay of it in Section 2019 of Public Law 119-103. Second, Soul scoped its statement to its own Out of Office THC line and to shipping — it is not saying every hemp product in America stops on 11 December, and neither are we.

What it does tell you is that a company with real inventory, real fulfilment contracts and real legal exposure has picked 11 December, printed it in its buy box, and built a discount ladder around it.

Worth knowing if Soul is your brand: our Soul CBD review found its core wellness range is zero-THC isolate, and isolate is the format least exposed to a rule that measures THC. The deadline language sits on the THC line, not the whole catalogue.

See what Soul is still shipping →

We Checked the Countdown Three Times. It Lands on 11 December Every Time.

Soul runs a live countdown beside the warning. Countdowns are dynamic, so a day count is worthless without the moment it was read. Here is every read we have, with our own arithmetic:

Three reads, two brands, three different days, one date. Soul’s timer decremented by exactly two days across exactly two calendar days, which tells you it is counting to a fixed target rather than rolling a fake urgency window. On 25 September it agreed, to the day, with the date Soul prints in words further down the same page.

The control that settles it: if these brands were pricing in the 12 November date most law firms are advising, the timer would have read 48 days on 25 September, not 77. It read 77.

One discrepancy, disclosed: a homepage load the same morning rendered “78 Days” while the collection page and the product page both rendered 77. We read that as a cached page rather than a second target date, and we have relied on the printed calendar date rather than the timer. We are not reconciling it beyond that.

Why They Are Right to Worry: 0.4 Milligrams Per Container

The number that ends these products is not a percentage. It is 0.4 mg combined total per container — covering total THC plus other cannabinoids the FDA is required to list as having similar effects, a list the FDA has never published.

“Container” is statutory, not marketing: “the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product.” A gummy jar is a container. So is a cream jar, which is why we put this on our topicals rankings as well — most coverage of this rule treats it as a gummies-and-drinks problem.

Jonathan Miller, general counsel of the U.S. Hemp Roundtable, put the scale of it plainly to Harvest Public Media on 17 September: “Even the vast majority of non-intoxicating CBD products have more than 0.4 milligrams of THC per container.”

Here is what that means for products these brands are selling right now. The milligram figures and counts are printed on each brand’s own page; the per-container totals and the multiples are our arithmetic, shown so you can check it.

Look at the top row. Soul’s Out of Office is a microdose gummy at 1.5 mg of THC — the lowest per-gummy THC figure in our verified price set — and it still carries roughly 112 times the coming per-container limit. That is the whole deadline in one line. This is not a rule that trims the strong products off the shelf; on the plain arithmetic it reaches nearly everything with THC in it, and a good deal that is sold as CBD.

Medterra is in that table for a reason: it prints no warning at all, and its Daily Delight gummy carries the same 100 mg per container as Five’s Daily Buzz. Silence on a storefront is not evidence that a product is unaffected.

The Contradiction Nobody Has Pointed Out

Here is the strange part. Several of these same storefronts are simultaneously telling you the 2018 standard still governs. All verbatim, all read 25 September 2026:

• Vena, on the very same page as its December warning: “Federally legal under the 2018 Farm Bill (less than 0.3% THC)”
• Soul, on the same homepage as its 11 December shipping cutoff: “Hemp-derived THC is federally legal under the 2018 Farm Bill.”
• Five: “delta-9 thc sourced from low-thc industrial hemp, like the kind five uses, is federally legal, with each state deciding their own laws.”
• Koi, on its delta-8 collection: “Delta 8 derived from hemp plants and maintaining less than 0.3% Delta 9 THC is legal in the United States.”

Every one of those sentences describes a legal test that Section 781 replaced. The old test was a delta-9 concentration under 0.3% by dry weight. The new test is total THC, plus the per-container milligram cap, plus exclusions for cannabinoids made outside the plant. Koi’s version is the most consequential, because it states the delta-9-only test on the delta-8 catalogue — and delta-8 is precisely the category whose status the rewrite puts in question.

We are not accusing anyone of deceiving shoppers. Nobody has updated this boilerplate because the compliance date has moved twice and the FDA has not published the lists the statute requires. But the effect on a shopper reading one page is real: the banner says the rules change in December and the footer says 2018 rules apply. If you want the current test rather than the 2018 one, that is what our cannabinoid-by-cannabinoid breakdown is for.

Three Brands Are Saying Nothing. Here Is What That Does and Does Not Mean.

Koi, Medterra and CBDfx printed no deadline language on any page we read. We checked Koi specifically for this story, on its homepage and its delta-8 collection, and found none.

What it might mean: a different legal read — 12 November is the majority practitioner view, and a brand planning for it may see no reason to advertise a December date it does not accept; a catalogue weighted toward products the brand believes survive; or simply a slower marketing department.

What it does not mean: that the product in your cart is unaffected. Nothing in the statute turns on whether a brand mentions it. The arithmetic above puts Medterra’s Daily Delight at the same 100 mg per container as the Five gummy that comes with a warning attached.

We would rather a brand told you. Of the six, three did.

Our Three Picks If You Are Stocking Up

Prices are list prices, on the dates shown. All of these brands run rotating discounts — Soul’s page showed tier discounts of 30–60% on 25 September, and Five showed a first-order code — so treat the list price as the number to compare and whatever you are shown at checkout as a bonus.

1. Soul Out of Office THC Gummies — the one with a published last-ship date

1.5 mg THC and 15 mg CBD per gummy, 30 count, list $54.00 (verified 25 September 2026). This is the product Soul has attached the countdown to, and the page states there is no reorder after 11 December. At 1.5 mg it is the lowest-dose product in this article; if you are new to THC edibles, read our dosing guide before you buy in bulk rather than after.

One thing to read carefully before you buy: the buy box offers prepaid multi-month supplies up to 360 gummies at $259.20, on a page that says the product cannot ship after 11 December and that there is no reorder. Those larger tiers appear to be bulk supplies bought up front rather than deliveries scheduled into 2027, and on Soul’s own framing that is the point of them. We have not tested the fulfilment. Check the delivery terms at checkout before you prepay for a year of anything with a printed end date.

Check Soul Out of Office pricing →

2. Five Daily Buzz — the brand doing the most specific triage

5 mg THC and 25 mg CBD per gummy, 20 count, $39.99 one-time or $29.99 on subscription (verified 22 September 2026). What earns Five the place here is not the gummy, which is spec-identical and price-identical to Medterra’s Daily Delight. It is that Five scoped its warning by dose — it tells you to stock up on its 10 mg and 15 mg gummies, and says nothing about its 2 mg microdose or this 5 mg tier. Reading that as catalogue triage against the coming cap is our inference, not Five’s statement. But of the three warnings, it is the only one specific enough to act on.

Check Five Daily Buzz pricing →

3. Vena xtra bliss — highest dose, longest-running warning, weakest paperwork

10 mg THC, 10 mg CBD and 2 mg CBG per gummy, 30 count, list $79.95 (verified 22 September 2026). Vena has been running its December line longer than any other brand we checked — we have now found it on five documents across three separate days. At 300 mg of THC per jar it is the furthest from the coming limit of the five products in the table above, which is either the reason to buy it now or the reason to be careful, depending on your risk appetite.

The caveat we always attach to Vena: its lab paperwork is the weakest of any brand we carry — COAs sit in a shared cloud folder with no batch lookup, no named lab and no dates. See our Vena CBD review for the detail.

Check Vena xtra bliss pricing →

Lab Testing: Read the COA Before You Buy a Year of Anything

A deadline is the worst possible time to relax on paperwork. If you are about to buy more of a product than you normally would, the certificate of analysis matters more, not less — you will be holding this inventory for months, and you will have no recourse to a brand that has stopped shipping the line.

Where these brands stand:

• CBDfx — best in class. Per-strength, per-batch COAs with batch numbers and dates, archived from 2020 onward.
• Five — public COAs.
• Medterra — QR batch lookup and an ISO 17025 claim, and it discloses openly that it does not test for herbicides or glyphosate. It never names its lab.
• Vena — weakest of the set: a shared cloud folder, no batch lookup, no lab named, no dates.

One specific thing to check on anything you are stockpiling: the total THC figure per container, not just the percentage. That is the number the new rule measures, and it is the number brands are least likely to print on the label. Our guide to reading a COA shows you where on the document to find it.

Buy If / Look Elsewhere

Buy now if: you already use a specific THC gummy and would be annoyed to lose it; you want the microdose category, which looks likely to be hit just as hard as the high-dose category on the per-container maths; you live in a state whose own deadline bites in November regardless of what happens federally — Illinois on 12 November, New Jersey in mid-November, Virginia on 1 November, and our state-by-state guide has the rest; or you are buying a product whose brand has published a last-ship date, because that is the clearest signal you will get.

Look elsewhere, or simply wait, if: you use CBD-only isolate products, which are the least exposed to a rule that measures THC; you were considering prepaying for a year of something on a page that says it cannot ship after December; you are shopping on price, in which case a deadline banner is the worst possible moment to buy, and our CBD gummies rankings and CBD oil rankings compare cost per milligram; or you are hoping for a reprieve, in which case H.R. 9830 is the bill to watch, and it has had no markup and no hearings.

What We Cannot Tell You

The date is contested, and anybody who tells you otherwise is selling something — possibly gummies.

Our reading is 11 December 2026, and it comes from the text. Section 2019 of Public Law 119-103 does not move the whole deadline; it carves two specific subclauses out of the delay, and those two subclauses cover cannabinoids that cannot be naturally produced by the plant. Everything else — including the total-THC test and the 0.4 mg container cap — waits until 11 December. The Congressional Research Service has described the delay as covering “most” of the new definition, which is the same structure in fewer words.

The other reading is 12 November 2026, and serious firms hold it — Bradley Arant is the clearest on that side. Illinois’s Department of Agriculture states 12 November. So the sensible position for a shopper is the one we have taken from the start: plan for 12 November and treat 11 December as upside. We do not write that delta-8 is legal until 11 December, and you should be sceptical of anyone who does.

One pattern worth knowing: the split tracks document age, not geography. Regulator documents written before September say November. Documents touched in September — Minnesota on the 4th, Rhode Island on the 11th — say 11 December. These three brands updated their storefronts in September.

And the agency that is supposed to resolve this has not. Verbatim, as we print it across our coverage: FDA has issued no 2026 Federal Register rulemaking directed at cannabinoids. Its only 2026 Federal Register discussion of delta-8 THC appears as a supporting example in the preamble to a proposed rule about something else — the 11 August 2026 GRAS proposed rule, Docket FDA-2025-N-3262 — and FDA’s own cannabis page is still marked content-current as of July 2024. The three cannabinoid lists the statute required were due 10 February 2026. They are 227 days late as of today.

The restrictions take effect regardless; the missing lists determine only how far past total THC the exclusions reach. We keep the running state of all of it on the federal hemp deadline tracker.

FAQ

Is there actually a federal THC ban on 11 December 2026?

There is no instrument called a “THC ban”. What exists is a redefinition of hemp that excludes products over a total-THC threshold and over 0.4 mg of combined cannabinoids per container, and that excludes certain cannabinoids made outside the plant. Section 2019 of Public Law 119-103 delays most of that to 11 December 2026 on our reading of the subclause structure; a competing reading puts the whole thing on 12 November 2026. “THC ban” is Soul’s phrase, not the statute’s.

Should I stock up?

That depends on something we cannot see: whether you use these products regularly enough that losing them would matter to you. If you buy a jar of THC gummies every month, buying a few months ahead is a reasonable hedge with a known cost. If you are being moved by a countdown timer into buying a year of something you tried once, that is the timer working as designed. Nothing about a deadline makes a product better value than it was last week.

Will CBD products be affected, or only THC products?

Both, on the plain reading. The 0.4 mg figure is a per-container cap on combined cannabinoid content, and full-spectrum CBD products contain trace THC by design. As Jonathan Miller of the U.S. Hemp Roundtable put it, “even the vast majority of non-intoxicating CBD products have more than 0.4 milligrams of THC per container.” CBD isolate products are the least exposed, because the THC is removed.

Does the cap apply to creams and balms?

Yes, on the statutory definition. “Container” means the innermost vessel in direct contact with the finished product, and a cream jar qualifies. We have not seen this point made in the mainstream coverage of the rule; we cover it on our topicals rankings.

Why do these brands say December when most law firms say November?

We do not know, and none of the three explains its reasoning. The honest answer is that the two dates come from reading the same provision differently: whether Section 2019 delayed the entire hemp redefinition, or carved only two subclauses out of the delay. We read it as a carve-in, which produces December. Three operators appear to have landed in the same place. That is a coincidence of conclusions, not a shared argument.

What happens to products I already own after the deadline?

The federal provisions we have read govern what can lawfully be produced, sold and offered for sale — Rhode Island, for one, has ordered non-compliant stock removed from licensed facilities before 11 December, and has said that “offered for sale” includes being displayed or advertised on a website. We have not seen any federal provision addressed to personal possession of products bought beforehand. State law varies and changes; this is not legal advice.

What We Will Be Watching

Three things, and we will update this page as each moves. Whether Koi, Medterra or CBDfx start printing a date, which would make it unanimous among the brands we recommend. Whether any of the three walks its date back, which would be just as informative. And whether the FDA publishes the cannabinoid lists it owed in February, which is the one event that would turn all of this from a reading into a rule.

Every brand named here is one we have reviewed and scored. The full comparison of all twelve is in Best CBD & Hemp Brands (2026). For the THC gummy category specifically, see our best delta-9 gummies rankings, and read our Five review for the brand doing the most careful triage of its own catalogue.

All storefront quotations in this article were transcribed on 25 September 2026 unless another date is given. Prices verified on the dates stated. Countdown values are dynamic and are printed here with the date they were read. Nothing here is legal advice.

Affiliate disclosure: MyCannabisReviews.com earns a commission when you buy through links on this page, at no extra cost to you. Every brand named here pays us that commission, and our scores are set by the review process rather than the payout. Every storefront quote above is transcribed verbatim from that brand’s own public pages, on the date stated.